发明名称 HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
摘要 Disclosed is a peptide having an ability to bind to an HLA-A*1101 molecule, and an ability to induce a cytotoxic T lymphocyte (CTL), the peptide consisting of the amino acid sequence Thr Gly Val Lys Pro Phe Gln Cys Lys, in which one to five amino acid(s) are substituted. Also disclosed are peptide dimers, the use of the peptides in the manufacture of a medicament, expression vectors, pharmaceutical compositions, WT1-specific cytotoxic T lymphocyte, wherein said cytotoxic T lymphocyte has been induced by the peptide and methods for induction of WT1-specific cytotoxic T lymphocytes.
申请公布号 NZ601175(A) 申请公布日期 2012.12.21
申请号 NZ20070601175 申请日期 2007.12.14
申请人 INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. 发明人 SUGIYAMA, HARUO
分类号 C12Q1/02;A61K31/7088;A61K38/00;A61K48/00;A61P35/00;A61P35/02;C07K14/82;C12N15/12;G01N33/574 主分类号 C12Q1/02
代理机构 代理人
主权项
地址